Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-01-03 @ 3:00 AM
Study NCT ID:
NCT02367794
Status:
COMPLETED
Last Update Posted:
2022-03-21
First Post:
2015-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-13
First Submit QC Date:
None
Study First Post Date:
2015-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-25
Results First Submit QC Date:
None
Results First Post Date:
2019-11-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-17
Last Update Post Date:
2022-03-21
Last Update Post Date Type:
ACTUAL